The main objectives of the present study were (1) to correlate PET/CT parameters to US and clinical measurements among RA patients and (2) to analyse variations in PET/CT parameters based on disease activity (remission, low/moderate activity or severe activity) defined by two classic composite indices, DAS28-CRP and Clinical Disease Activity Index (CDAI) scores. This evidence concerns the gene CRP and rheumatoid arthritis.